home / stock / akro / akro short
Short Information | Akero Therapeutics Inc. (NYSE:AKRO)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 76,480 |
Total Actual Volume | 2,724,166 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 3,824 |
Average Short Percentage | 2.38% |
Is there a AKRO Short Squeeze or Breakout about to happen?
See the AKRO Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
02-12-2020 | $27.10 | $24.97 | $27.10 | $24.64 | 89,888 | 762 | 0.85% |
02-11-2020 | $27.08 | $27.05 | $27.27 | $26.50 | 98,425 | 257 | 0.26% |
02-10-2020 | $27.17 | $26.92 | $27.215 | $26.24 | 90,334 | 1,510 | 1.67% |
02-07-2020 | $26.53 | $26.09 | $26.92 | $25.34 | 110,269 | 826 | 0.75% |
02-06-2020 | $26.23 | $26.92 | $27.16 | $26.23 | 148,895 | 4,737 | 3.18% |
02-05-2020 | $25.43 | $26.07 | $26.26 | $25.22 | 66,310 | 329 | 0.5% |
02-04-2020 | $24.74 | $25.40 | $25.97 | $24.3921 | 209,573 | 4,375 | 2.09% |
02-03-2020 | $24.60 | $24.65 | $25.32 | $24.21 | 122,856 | 1,181 | 0.96% |
01-31-2020 | $25.00 | $24.69 | $25.26 | $24.25 | 104,168 | 1,856 | 1.78% |
01-30-2020 | $24.05 | $24.90 | $25.29 | $23.75 | 81,932 | 2,603 | 3.18% |
01-29-2020 | $23.50 | $23.90 | $24.74 | $23.50 | 54,855 | 3,162 | 5.76% |
01-28-2020 | $23.76 | $23.70 | $24.36 | $23.467 | 67,487 | 2,057 | 3.05% |
01-27-2020 | $24.42 | $23.59 | $25.75 | $23.26 | 124,639 | 2,591 | 2.08% |
01-24-2020 | $24.70 | $24.71 | $25.16 | $23.16 | 152,605 | 1,961 | 1.29% |
01-23-2020 | $23.40 | $24.50 | $25.94 | $23.24 | 167,790 | 5,790 | 3.45% |
01-22-2020 | $23.04 | $23.31 | $24.09 | $21.84 | 216,074 | 5,249 | 2.43% |
01-21-2020 | $21.44 | $22.94 | $23.31 | $21.00 | 377,535 | 20,222 | 5.36% |
01-17-2020 | $19.79 | $20.18 | $20.45 | $19.7101 | 120,240 | 2,207 | 1.84% |
01-16-2020 | $19.79 | $19.69 | $20.0019 | $19.67 | 234,423 | 13,723 | 5.85% |
01-15-2020 | $19.85 | $19.69 | $20.08 | $19.67 | 85,868 | 1,082 | 1.26% |
News, Short Squeeze, Breakout and More Instantly...
Akero Therapeutics Inc. Company Name:
AKRO Stock Symbol:
NYSE Market:
SOUTH SAN FRANCISCO, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic disease, today announced the appointment of Scott Gangloff as Chief Technology Officer. ...
LOS ANGELES, April 28, 2024 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class...
(NewsDirect) Investors are making a lot of money on obesity plays. Obesity is at epidemic proportions, so it's easy to see why obesity drugs including GLP-1 agonists have exploded in the marketplace. This class of drugs was originally designed to manage blood sugar levels in diabetics but was...